SCHEMBL4067141

SCHEMBL4067141

CC(=O)N1CCN(CC2CCN(C)CC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
CACNA2D1 P54289 1/20 0.55
CACNA1B Q00975 1/20 0.55
CACNB1 Q02641 1/20 0.55
CACNA1C Q13936 1/20 0.55
PIK3CD O00329 1/20 0.46
SIGMAR1 Q99720 1/20 0.41
CXCR3 P49682 1/20 0.41
HRH3 Q9Y5N1 1/20 0.40
NCF1 P14598 1/20 0.39
CNR1 P21554 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
BDKRB1 P46663 1/20 0.39
GNAI3 P08754 1/20 0.38
GNAO1 P09471 1/20 0.38
GNAI1 P63096 1/20 0.38
DRD3 P35462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23340463 0.94 CACNA2D1 (0.50) CYP1A2TDP1CACNA2D1CACNA1BCACNB1
SCHEMBL18713017 0.93 CYP1A2 (0.55) CYP1A2TDP1CACNA2D1CACNA1BCACNB1
SCHEMBL27260584 0.89 CACNA2D1 (0.53) CYP1A2TDP1CACNA2D1CACNA1BCACNB1
SCHEMBL4550243 0.89 PIK3CD (0.52) CYP1A2TDP1CACNA2D1CACNA1BCACNB1
SCHEMBL23173214 0.88 CACNA2D1 (0.53) CYP1A2TDP1CACNA2D1CACNA1BCACNB1
SCHEMBL27895314 0.87 CACNA2D1 (0.56) CYP1A2TDP1CACNA2D1CACNA1BCACNB1
SCHEMBL27571743 0.86 CACNA2D1 (0.58) CYP1A2TDP1CACNA2D1CACNA1BCACNB1
SCHEMBL13993923 0.85 SMN1; SMN2 (0.49) CYP1A2TDP1CACNA2D1CACNA1BCACNB1
SCHEMBL23173333 0.84 PIK3CD (0.44) CYP1A2TDP1CACNA2D1CACNA1BCACNB1
SCHEMBL25513778 0.84 PIK3CD (0.44) CYP1A2TDP1CACNA2D1CACNA1BCACNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066659-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-06-10 EP claimed
WO-2008040492-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-04-10 WO claimed
WO-2024073626-A2 ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS NUVATION BIO INC. (US) 2024-04-04 WO disclosed
EP-2066659-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-06-10 EP disclosed
WO-2008040492-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-04-10 WO disclosed